OptraSCAN Digital Pathology Launches On-Demand Image Analysis Suite at USCAP 2017

| March 6, 2017 | 0 Comments

Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN, Inc. today announced the launch of its next generation, On-Demand suite of image analysis software for digital pathology, which includes OptraASSAYSTM, CARDSTM and OptraPROCESSTM. The image analysis suite supports both individual, […]

Continue Reading

FDA Approves First Liquid Biopsy Test for Use in Non-Small Cell Lung Cancer

| June 1, 2016 | 0 Comments

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended for detection of these specific mutations in circulating-free tumor DNA (cfDNA) from plasma for first […]

Continue Reading

Join Horizon and Visiopharm for a Webinar Series on New, Innovative Technologies for Quality Control of Immunohistochemistry

| July 5, 2015 | 0 Comments

Immunohistochemistry (IHC) stained tissue sections are read and interpreted by a pathologist using a microscope, or on a computer monitor as routine use of digital pathology continues to grow. Regardless of interpretation method, It is well known and documented that manual assessment of biomarker expression is associated with significant inter and intra-reader variability. Furthermore, inter […]

Continue Reading